Come up with a name for your new list and we'll add to it:
Adverum Biotechnologies raised a round of funding on October 01, 2012. Investors include
National Eye Institute.
Adverum Biotechnologies, formerly Avalanche Biotechnologies, is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases.…